AltG Investment Research Lab
Investment Research In Practise
Is Disney India (With Or Without Blackstone) A $10 Billion Opportunity Or Not Quite?
Why Is JSW's Sajjan Jindal Betting On $10Billion MG Motor Investment Opportunity?
The Agilus Diagnostics IPO: What You Should Be Looking For In The 2nd Largest Indian Diagnostics?
Godfrey Phillips's 24SEVEN Deal: Spin-Off To Create $10 Billion Market Cap
Nirma's Glenmark Life Sciences Deal for $680 Million: Strategic Move into Pharma
Barbeque Nation: A Secret $5Billion CDR Company Taking On QSR in India
Bloomberg's TATA Assessment: Correct Conclusion, Constrained Content
2023 And Beyond: Premiumisation & Decentralisation
So Why Do We Write A Newsletter?
Decoding The Playbook For Generating Stellar Returns In India’s IPO Market
Shifting Fortunes: How Joe Biden's China Investment Ban Is Set to Propel India's Private Markets
M&M’s Investment In RBL Bank: How Not To Do Capital Allocation
Investment Tear Sheet: India's B2B Database Businesses
The Blackstone-Cipla Deal: Platforms The Holy Grail Of India Investments
India's Missing Middle 'Platforms': Unveiling the Untapped Goldmine That Could Change Everything!
Decoding AltG's Investment Criteria for Allocating a Billion Dollars In India
Indian Corporate Carve-Outs: Why Major Companies are Spinning Off to Soar to New Heights!
Venture Debt In Indian Startups: The Valley Of Death Or The Promised Land?
The Top 3 Trends Private Equity Should Be Watching in H2 2023
The PharmEasy Saga: An SOS Call and A Billionaire's Low Ball